188 related articles for article (PubMed ID: 33459820)
21. Prognostic impact of the "Sekhar grading system for cranial Chordomas" in patients treated with pencil beam scanning proton therapy: an institutional analysis.
Hottinger AL; Bojaxhiu B; Ahlhelm F; Walser M; Bachtiary B; Zepter S; Lomax T; Pica A; Weber DC
Radiat Oncol; 2020 May; 15(1):96. PubMed ID: 32375820
[TBL] [Abstract][Full Text] [Related]
22. Tumor-biology and current treatment of skull-base chordomas.
Pamir MN; Ozduman K
Adv Tech Stand Neurosurg; 2008; 33():35-129. PubMed ID: 18383812
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
Eisenberg MB; Woloschak M; Sen C; Wolfe D
Surg Neurol; 1997 Feb; 47(2):156-60; discussion 160-1. PubMed ID: 9040820
[TBL] [Abstract][Full Text] [Related]
24. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Hug EB; Slater JD
Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
[TBL] [Abstract][Full Text] [Related]
25. Pediatric Chordomas: A Population-Based Clinical Outcome Study Involving 86 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011).
Lau CS; Mahendraraj K; Ward A; Chamberlain RS
Pediatr Neurosurg; 2016; 51(3):127-36. PubMed ID: 26881831
[TBL] [Abstract][Full Text] [Related]
26. Endonasal Endoscopic Resection and Radiotherapy in Skull Base Chordomas.
Zhang HK; Sun XC; Hu L; Wang JJ; Wang DH
J Craniofac Surg; 2016 Oct; 27(7):e709-e713. PubMed ID: 27564072
[TBL] [Abstract][Full Text] [Related]
27. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
[TBL] [Abstract][Full Text] [Related]
28. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas.
Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J
Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429
[TBL] [Abstract][Full Text] [Related]
29. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
30. Contemporary management of clival chordomas.
Campbell RG; Prevedello DM; Ditzel Filho L; Otto BA; Carrau RL
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):153-61. PubMed ID: 25692630
[TBL] [Abstract][Full Text] [Related]
31. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma.
Freeman JL; DeMonte F; Al-Holou W; Gidley PW; Hanna EY; Kupferman ME; Su SY; Raza SM
Acta Neurochir (Wien); 2018 Apr; 160(4):731-740. PubMed ID: 29270681
[TBL] [Abstract][Full Text] [Related]
32. Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas.
Mercado CE; Holtzman AL; Rotondo R; Rutenberg MS; Mendenhall WM
Head Neck; 2019 Feb; 41(2):536-541. PubMed ID: 30537295
[TBL] [Abstract][Full Text] [Related]
33. The Significance of Intraoperative Magnetic Resonance Imaging in Resection of Skull Base Chordomas.
Metwali H; Samii A; Gerganov V; Giordano M; Fahlbusch R; Samii M
World Neurosurg; 2019 Aug; 128():e185-e194. PubMed ID: 31003024
[TBL] [Abstract][Full Text] [Related]
34. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
Freeman JL; Kaufmann AB; Everson RG; DeMonte F; Raza SM
Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):27-36. PubMed ID: 29912434
[TBL] [Abstract][Full Text] [Related]
35. Disease outcomes for skull base and spinal chordomas: a single center experience.
Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
[TBL] [Abstract][Full Text] [Related]
36. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
Luo P; Wang X; Zhou J; Li L; Jing Z
Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
[TBL] [Abstract][Full Text] [Related]
37. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
[TBL] [Abstract][Full Text] [Related]
39. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
40. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
